COO
COOPER COMPANIES, INC.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$55.29
+2.82%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$54.50
From 52W high−34.43%
Volume8.76M
Market cap$10.51B
P/E (TTM)18.9x
P/S (TTM)2.5x
Div yield—
Key dataSep 18, 2026
Open
$54.50
From 52W high
−34.43%
Volume
8.76M
Market cap
$10.51B
ValuationView details →
P/E (Fwd)
12.1x
EV/EBITDA
14.2x
P/E (TTM)
18.9x
RSI (14)
25.7
MomentumView details →
1D Return
+2.82%
YTD Return
−32.50%
SummaryUpdated Jul 1, 2026
The Cooper Companies, Inc. (NYSE:COO) is a global medical device company founded in 1958 and headquartered in San Ramon, California. The company has evolved from its origins into a leading manufacturer of contact lenses and women's healthcare products. Cooper Companies went public in 1983 and has grown through strategic acquisitions and organic expansion to become a significant player in the medical devices industry, operating in over 100 countries worldwide with annual revenues approaching $4 billion.
Similar companies
Latest newsMore news →
Activist investor Jana Partners called on Cooper Cos. to search for a new CEO.2d agoActivist hedge fund Jana Partners demanded that contact lens maker CooperVision replace its CEO and evaluate a sale of its core business.3d agoShares of The Cooper Companies fell $9.31 (-14.6%) on September 10, 2026, after the company reported Q3 2026 results that included U.S. channel inventory destocking and other negative surprises.8d ago